Home New Trending Search
About Privacy Terms
#
#IPSC
Posts tagged #IPSC on Bluesky

Join our lab studying neuronal resilience and #Neurodegeneration using #iPSC and #StemCells at Chiang Mai University—apply now to advance brain resear

Research Positions – Stem Cells & Neurodegeneration
Center of Multidisciplinary technology for Advanced Medicine

See the full job description on j

0 0 0 0
Preview
Century Therapeutics Reports Full Year 2025 Financial Results and Business Updates CNTY-813, lead beta islet cell therapy program as a potential functional cure for type 1 diabetes, in Investigational New Drug (IND)-enabling studies; IND submission expected in 4Q 2026 to support anticipated initial clinical data in 2H 2027 CNTY-308, a CD19-targeted CAR-iT cell therapy engineered

#IPSC Century Therapeutics Reports Full Year 2025 Financial Results and Business Updates

www.stocktitan.net/news/IPSC/century-therap...

0 0 0 0
Post image

New organoid research shows SMA affects far more than motor neurons, revealing widespread CNS disruptions. Using CorePlate™ HD MEAs, researchers found reduced activity, glutamate hyperexcitability, and showed early ASO treatment can rescue function. Huge thanks to the team! #iPSC #HDMEA #3Brain

1 1 1 0

Offre d'emploi | Ingénieur·e d'études plateau technique iPSC – Sorbonne Université Concours externe | Affectation : Unité Dev2A – IBPS, Paris
www.enseignementsup-recherche.gouv.fr/fr/recruteme...
#Recrutement et #Ingénieurd’études#SorbonneUniversité #CellulesSouches #iPSC #Recherche #CNRS #Inserm

2 2 0 0
Post image

Catching up on Aiken Lab milestones…
October 2025: first cells in the TC hood! The lab officially opens for science. 🧫🔬

#LabLife #NewLab #iPSC #Neuroscience

6 0 0 0
Post image

Scientists from the Korea Research Institute of Bioscience and Biotechnology report the development of a patient-specific, #iPSC-derived multi-organ pharmacokinetics/pharmacodynamics evaluation platform for NF1-mutant #BreastCancer. | @sigtrans-sttt.bsky.social

🧫 https://go.nature.com/46J1Y05

0 0 0 0
Preview
BrainXell Unveils Groundbreaking Sensory Neurons for Neuroscience Research BrainXell has launched a new platform of human iPSC-derived sensory neurons, enabling advanced research in pain biology and neuroscience.

BrainXell Unveils Groundbreaking Sensory Neurons for Neuroscience Research #United_States #Madison #iPSC #BrainXell #sensory_neurons

0 0 0 0
Preview
iPSC治療の新時代を共に切り拓く国際的な提携 国際細胞・遺伝子治療学会と日本再生医療学会が、iPSCに基づく治療法の向上を目指す5年間の戦略的提携を発表しました。

iPSC治療の新時代を共に切り拓く国際的な提携 #再生医療 #iPSC #国際提携

国際細胞・遺伝子治療学会と日本再生医療学会が、iPSCに基づく治療法の向上を目指す5年間の戦略的提携を発表しました。

0 0 0 0
Preview
Significant International Partnership to Advance iPSC Therapies Launched in Kobe A groundbreaking partnership between ISCT and JSRM aims to enhance global access to iPSC therapies, shaping the future of regenerative medicine.

Significant International Partnership to Advance iPSC Therapies Launched in Kobe #Japan #Kobe #iPSC #ISCT #JSRM

0 0 0 0
Preview
REPROCELL Launches Innovative GMP Master Cell Bank for Clinical iPSCs REPROCELL has initiated the production of a GMP-compliant Master Cell Bank, enhancing their clinical iPSC services to streamline therapy development.

REPROCELL Launches Innovative GMP Master Cell Bank for Clinical iPSCs #USA #GMP #iPSC #REPROCELL #Beltsville,_MD

0 0 0 0
Preview
REPROCELL's Launch of GMP-Compliant Master Cell Banks for Clinical iPSCs REPROCELL has introduced GMP-compliant Master Cell Banks for clinical induced pluripotent stem cells (iPSCs), streamlining the process for cell therapy development.

REPROCELL's Launch of GMP-Compliant Master Cell Banks for Clinical iPSCs #USA #Beltsville #GMP #iPSC #REPROCELL

0 0 0 0
Preview
REPROCELL Unveils New Master Cell Bank Service for Clinical iPSCs REPROCELL has launched a new service for the production of induced pluripotent stem cells, ensuring compliance with FDA Good Manufacturing Practices. This service enhances efficiency for cellular therapy developers.

REPROCELL Unveils New Master Cell Bank Service for Clinical iPSCs #USA #Beltsville #iPSC #REPROCELL #StemRNA

0 0 0 0
Post image

Tomorrow is Rare Disease Day
While individual rare diseases affect a small number of people, their collective impact is a global health challenge.
#RareDiseaseDay #GeneEditing #iPSC #Biotech

2 0 1 0
Post image

⏳ Only one week left to register | Open-access iPSC training – 6 March

If you work with iPSCs and want to strengthen reproducibility and impact, come join us!

📅 6 March | Registration closing soon

lnkd.in/extr-ExX

#iPSC #Training #raredisease #ERDERA #EBiSC

0 1 0 0

Have you ever cried in the tissue culture room because your #iPSC transgene got silenced after differentiation?

I have. Many, many times.

So we built TK4, a PiggyBac vector designed to resist silencing.

Now available on @addgene.bsky.social:
#239047 / #239046
Would love to hear your thoughts.

2 1 0 1
Please wait whilst we redirect you All content on this site: Copyright © 2026 Elsevier B.V., its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.

Losing sleep over #iPSC transgene silencing after differentiation?
Same here.

Bright in iPSCs.
Gone after differentiation.

Our paper in @cp-cellstemcell.bsky.social maps what actually keeps expression on👇
www.cell.com/cell-stem-ce...
🔗 Free access (50 days):
www.sciencedirect.com/science/auth...

12 10 1 0
Post image

Next week marks our first conference of 2026 with @alzheimersresearchuk.org! Our team are ready to go and looking forward to great science and catching up with collaborators and new faces alike. What more could you ask for?
#iPSC #ARUK2026 #EBiSC #Alzheimer's #Dementia

2 0 0 0
Post image

Many thanks @nature.com for selecting our image of a fully #iPSC derived #BBB (#blood-brain-barrier) as 'Image of the Week' in Nature Briefings: mailchi.mp/nature/trans... 😀 Find the image in action in our primary research paper here: rdcu.be/eUIl3

5 0 0 1
Preview
Bayer/BlueRock、iPSC由来細胞治療OpCT-001が網膜色素変性でFDAオーファンドラッグ指定取得 | STELLANEWS.LIFE STELLANEWS.LIFE(ステラニュース・ライフ)は、科学や技術、医薬品分野における最新の研究成果や発見 | STELLANEWS.LIFE(ステラニュース・ライフ)は、科学や技術、医薬品分野における最新の研究成果や発見

FDA grants Orphan Drug Designation to BlueRock Therapeutics’ investigational cell therapy OpCT-001 for the treatment of retinitis pigmentosa

stellanews.life/technology/8...

#RetinitisPigmentosa #iPSC #CellTherapy #Bayer #BlueRock #FDA #OrphanDrug #ClinicalTrials

0 0 0 0

【BayerとBlueRockのiPSC由来細胞治療OpCT-001、FDAよりオーファンドラッグ指定を取得】

✔ 網膜色素変性(RP)を対象としたiPSC由来細胞治療OpCT-001がFDAのオーファンドラッグ指定を取得 ✔ 第1/2a相試験「CLARICO」にて安全性、忍容性、臨床アウトカムへの影響を評価中 ✔ 遺伝性網膜疾患における視細胞消失に対し、新たな治療選択肢となる可能性を追求

#網膜色素変性 #iPSC #細胞治療

0 0 1 0
Post image

🫀🧫 Two of our favourite things in one place - EBiSC iPSCs and cardiac research - shown here as UKBi005-A iPSC line differentiated to cardiomyocytes stained with cTNT (green) and Connexin-43 (violet). 💚

#EBiSC #iPSC #CardiacResearch #Cardiomyocytes #StemCellResearch #DiseaseModelling

1 1 1 0
Preview
Reprocell Launches StemEdit Services to Advance Clinical Gene Editing With AI-Designed Tools -- MedCloudInsider New offering combines iPSC technology and AI-driven editing design to support translational and clinical research.

REPROCELL launched StemEdit, a clinical gene-editing service using OpenCRISPR-1 to deliver precise gene-edited iPSC lines suitable for both preclinical and clinical workflows.

Here’s what it is and why it matters: https://ow.ly/cWjk50Y9flU

#CRISPR #GeneEditing #iPSC #Biotech #AI

0 0 0 0
Post image

📣 Open-access iPSC training | 6 March
EBiSC and ERDERA are joining forces to host a free, open-access training session on best practices for the use and sharing of iPSC lines.

Register here and join us to help strengthen iPSC research!
lnkd.in/extr-ExX
#iPSC #raredisease #stemcell #diseasemodelling

1 1 1 0
Post image

📢 We can't wait to chat with Dr. Joseph Wu from @stanfordcvi.bsky.social!

Tune in tomorrow to learn about his early #iPSC work, his team's research on drug screening and translation, and promoting his trainees' success!

1 1 0 0
Post image

Have Your Say and shape hPSCreg!

The human pluripotent stem cell registry (hPSCreg) manages EBiSC’s cell line data and supports biobanking distribution operations. hPSCreg would like your input via a survey focused on the future of stem cell research.
s.fhg.de/Y9CG
#iPSC #hESC #stemcell #research

1 1 0 0
Post image

💡Application Note: Differentiation of induced pluripotent stem cells (iPSCs) into neuroectoderm; zurl.co/GEzsS

All growth factor required can be purchased as a kit saving 26%; zurl.co/YL8bk

#iPSC #ectoderm #stemcells

0 0 0 0
Post image

How do we better model cholinergic pathways? By building human brain assembloids. Using CorePlate™ 3D electrodes, the 𝗟𝗶𝘂 𝗟𝗮𝗯 recorded high-res data from hnbM-cortical projections, even transplanting them into mice to establish human-derived pathways. #3Brain #iPSC #HDMEA #Organoids #Assembloids

0 0 1 0
Post image

🫀 Up-scaling the differentiation of functional cardiomyocytes using different bioreactors - a key area of research for our team! Interested on collaborating on this together?
Get in touch: ebisc.org/contact

#iPSC #StemCell #Cardiac #Cardiomyocyte

0 1 0 0
Post image

💡Application Note: Differentiation of induced pluripotent stem cells (iPSCs) into mesoderm; zurl.co/SCl5N

The growth factors needed can be purchased as a kit saving 36%; zurl.co/ue2IN

#iPSC #mesoderm #stemcells

0 0 0 0

JUST IN: ( NASDAQ: #IPSC ) IPSC Price Target Alert: $4.00. Issued by Piper Sandler

0 0 0 0